#AntiVEGF hashtag - Bluesky

@rcatanho.bsky.social

5 days ago

Intravitreal Anti-VEGF and Systemic Outcomes After Cardiovascular Events This cohort study evaluated if pericardiovascular event treatment is associated with mortality or major sequelae in patients receiving intravitreal anti–vascular endothelial growth factor (anti-VEGF) ...

Terapia anti-VEGF cerca del evento CV no se asocia con una mayor mortalidad o morbilidad, independientemente del anti-VEGF, por lo que es seguro continuar con la terapia intravítrea sin modificarla durante el evento CV #AntiVEGF #CVevent jamanetwork.com/journals/jam...

0 0 0 0

@seldon-dengyue.bsky.social

1 week ago

🚨 El tratamiento del cáncer colorrectal está cambiando…
Hoy, 5 fármacos clave están redefiniendo la estrategia terapéutica:
💊 Más precisión
💊 Más opciones
💊 Mejores resultados

#CáncerColorrectal #Quimioterapia #AntiVEGF
#AntiEGFR #Angiogénesis #TerapiasCombinadas #DengYueMedicinasEnHongKong

0 0 0 0

@seldon-dengyue.bsky.social

1 month ago

#HCC: 3 enfoques terapéuticos que están cambiando el panorama clínico
🔹 PD-1
🔹 Anti-VEGF
🔹 TKI

📎 Más información: dengyuepharma.com
📧 info@dengyuemed.com
#CarcinomaHepatocelular #InmunoOncología #AntiVEGF #TKI #PD1 #TerapiaSistémica #DengYueMedicinasEnHongKong

0 0 0 0

Trials Change Lives

@trialschangelives.bsky.social

2 months ago

International Kite Day Let your colorful, creative masterpieces take to the sky as we celebrate International Kite Day.

#CochraneDaily On International Kite Day nationaltoday.com/internationa... the 2023 update of #CochraneLibrary network meta-analysis of anti‐vascular endothelial growth factor for diabetic macular oedema added in the KITE trial of brolucizumab.
www.cochranelibrary.com/cdsr/doi/10....
#AntiVEGF #DMO

0 0 0 0

Ophthalmology Advisor

@ophthalmologyadv.bsky.social

5 months ago

Retinopathy of Prematurity Anti-VEGF Monotherapy Outcomes Remain Strong Long Term - Ophthalmology Advisor Investigators evaluated long-term outcomes for ROP patients with persistent avascular retina initially treated with anti-VEGF injections without laser therapy.

#AAO2025: Even with persistent areas of avascular retina (#PAR) after #AntiVEGF monotherapy, outcomes for patients with #RetinopathyOfPrematurity remain favorable.

Read more: https://bit.ly/4ho41dU

#Ophthalmology #MedSky #EyeSky

0 0 0 0

Ophthalmology Advisor

@ophthalmologyadv.bsky.social

5 months ago

Foselutoclax Delivers Durable Vision Benefits in Diabetic Macular Edema - Ophthalmology Advisor Presenters at the AAO discussed phase 2 clinical trial results evaluating the safety and efficacy of foselutoclax (UBX1325) compared with aflibercept in diabetic macular edema.

#AAO2025: #Foselutoclax can improve best-corrected visual acuities in patients with #DiabeticMacularEdema and #VisualAcuity deficits, despite prior #AntiVEGF treatment. Presented at AAO 2025 by David Eichenbaum, MD, of Retina Vitreous Associates of Florida.

Read more ➡️: bit.ly/4nd34Xa

0 0 0 0

@yuvip.bsky.social

5 months ago

Anti-VEGF Market Size, Growth Analysis, Trends 2035 | MRFR Anti-VEGF Market is projected to register a CAGR of 4.30% to reach USD 39.60 Billion by the end of 2035, Anti-VEGF Market Product, Disease, Region | Anti-VEGF Industry

👁️ Vision-saving innovation! The Anti-VEGF Market grows with increasing demand for advanced eye therapies. Full report: www.marketresearchfuture.com/reports/anti... #Ophthalmology #AntiVEGF #HealthcareTrends

0 0 0 0

ilQuaderno.it

@ilquaderno.bsky.social

6 months ago

Maculopatie, nuove conferme su efficacia anti-Vegf a intervalli fino a 6 mesi (Adnkronos) - Sono stati presentati alla 25esima edizione del Congresso Euretina, in corso a Parigi fino al 7 settembre, importanti aggiornamenti su aflibercept 8 mg, con dati real world, che confermano la sua efficacia terapeutica per ...

TI POTREBBE INTERESSARE: Maculopatie, nuove conferme su efficacia anti-Vegf a intervalli fino a 6 mesi ... LEGGI TUTTO #maculopatie #aflibercept #antiVEGF #terapia #congresso

0 0 0 0

Simon J. Clark

@prof-clark.bsky.social

9 months ago

EU okays extended treatment interval for Bayer, Regeneron's higher-dose Eylea Bayer gained approval in the EU for an extended treatment interval of its higher-dose version of Eylea (aflibercept), something that was ...

EU okays extended treatment interval for Bayer, Regeneron's higher-dose Eylea buff.ly/4Yn1bT6

This will move the goalposts for assets whose USP is less frequent dosing. How much better are they going to have to be now? Once a year? #wetAMD #antiVEGF #eylea

0 0 0 0

Simon J. Clark

@prof-clark.bsky.social

11 months ago

Genotypes of SNPs of key genes regulate susceptibility and drug sensitivity to neovascular AMD in the human population - PubMed These genotype differences facilitate the selection of individualised treatment options towards obtaining the most efficacious clinical treatment. These findings need to be validated by studies with…

Interesting small study highlighting gentotypic differences in good and poor responders to an anti-VEGF drug in patients suffering from neovascular AMD. Another step towards personalised medicine approaches? #AMD #antiVEGF buff.ly/oEXdGKY

0 0 0 0